PneumoniaVRINCT01279863
VRI in Children With Acute Respiratory Symptoms.
An observational study of Pneumonia and Fever, run by Rabin Medical Center at 1 site in Israel.
Trial summary
The VRI technology provides a radiation free dynamic image of the lung, by using a combination of well-known technologies, i.e. acoustic sensors, and a proprietary algorithm. The aim of the study is to determine if the VRI examination may contribute to the diagnosis and follow up of pneumonia in children, and… Read more about this study
- Who is it for?
- Ages 3 to 18 years
- How many people
- 80 participants
- Where
- 1 siteIsrael
- Study dates
- Feb 2011to Feb 2012
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Children, 3-18 years old
Who may be able to join
- Patients must meet all of the following inclusion criteria to be entered into the study:
- Subject's parent or legal guardian, is able and willing to read the Informed Consent, understands the Informed Consent, and provides written Informed Consent for the subject; if the minor child is in fact able to give consent, the minor's consent must be obtained in addition to the consent of the minor's legal guardian.
- Boy or girl in the age range of 3-18 years.
- Patient presented with acute respiratory complaints, acute cough, onset of shortness of breath, or fever.
- Patient referred by ED physician and presented for CXR.
Who cannot join
- Any of the following will exclude the patient from study:
- Body habitus or skin condition that might prevent the placement of the sound sensors on the back (e.g. severe scoliosis, kyphosis, chest wall deformation, skin lesion on the back or compression fracture);
- Potentially contagious skin lesion on the back;
- 4. Subject has had lung surgery; 5. Subject was prescribed the CXR for monitoring or follow up of a lung condition that pre-existed the current, acute symptoms.
Trial locations and contacts
1 site in 1 country.
Liora Kornreich, MD contact
Israel1 site
Schneider medical center of Israel, Imaging Department
Petah Tikva
About this study
Official title: Vibration Response Imaging (VRI) in Children With Acute Respiratory Symptoms.
The VRI technology provides a radiation free dynamic image of the lung, by using a combination of well-known technologies, i.e. acoustic sensors, and a proprietary algorithm. The aim of the study is to determine if the VRI examination may contribute to the diagnosis and follow up of pneumonia in children, and therefore reduce the number of chest radiographs and the exposure to ionizing radiation. Children referred by ED for chest x-ray,for the evaluation of pneumonia, will undergo VRI as well. The two modalities will be read independently and then the findings will be compared, in order to asses the potential role of the VRI to the management of pneumonia in children.
Read the detailed description
Background Several widely used imaging modalities are available today for the human lung. Conventional radiology, CT, and to a lesser extent MRI, as well as nuclear medicine in some indications are well established and most commonly used. Methods using acoustic signals, most notably ultrasound, have not been successfully developed. This is primarily due to the fact that the acoustic damping of the lung parenchyma is prohibitively high at high frequencies .
Assessment of alterations in the structure and function of thoracic organs that occur in disease often gives rise to measurable changes in lung sound production and transmission. Acoustic assessment with a stethoscope is a commonly used method to assess these structural and functional changes. However, auscultation with a stethoscope has many limitations. It is a subjective process that depends on the individual's own hearing, experience and ability to differentiate between different sound patterns. In addition, quantitative measurements and documentation are not easy to be produced. Moreover, the stethoscope has a frequency response that attenuates frequency components of the lung sound signal above 120Hz, and the human ear is not very sensitive to the lower frequency band.
Analysis of acoustic sounds by computer is more likely to be successful in clinical applications when it is based on mathematical models of the underlying physical mechanisms of respiratory sound production. Such models allow for the interaction of mechanical forces, airflow and sound transmission within the respiratory tract to be understood and related to the different disease processes.
The VRI technology, to the best of our knowledge, is the first of its kind to provide a radiation free dynamic image of the lung, by using a combination of well-known technologies, i.e. acoustic sensors, and a proprietary algorithm.
Since the acoustic response of a body depends on its structural properties, complex structures can exhibit acoustic responses, which may vary in space, time and frequency. Moreover, any structural alteration, such as a bronchial obstruction or space occupying infiltration, is reflected by a corresponding modification of the acoustic response.
The VRI takes advantage of this physical principle, by means of an imaging system. By attaching a two dimensional matrix of acoustic transducers to the back of the patient, a dynamic image that integrates the acoustic characteristics of the underlying structure is generated.
The VRI device may provide a complementary diagnostic tool for lung examination and aid the physician in determining whether a chest x-ray should be performed.
Study Device The VRI system is a computerized-based, radiation free device intended for non-invasive recording, audio reproduction, and dynamic image display of vibration response to the airflow during respiration. (The VRI system incorporates a flow volume sensor in which the patient may/may not breathe through it). The VRI system incorporates pressure sensors (electronic stethoscopes) that have been specially adapted to capture and record the energy created by the airflow in the lungs during the respiration process. Sensors are mounted in two sensor matrices, which are attached to the patient's back by a low vacuum and/or biocompatible medical stickers method. The signals are transmitted through wires from the sensor matrix to the hardware board. The analog signals are then processed online on a multi-channels hardware board by amplifying, sampling and A/D conversion. The digital data is transmitted to the PC platform. Once on the PC platform, Deep Breeze proprietary algorithms generate the dynamic lung image.
Risk Analysis Unlike X-Ray based methodologies, which expose the subject to ionization radiation, the VRI is radiation free.
The VRI elements that come into contact with the subject's skin are biocompatible.
The VRI has been approved by an independent authorized laboratory to be electrically safe.
In addition, so far, no adverse events, risks of illness, injuries, or discomforts have been associated with the use of the VRI in previous studies. Therefore, it is reasonable to conclude that the VRI does not pose any risk to the subjects and/or operators.
Study Rationale Various reports and studies have suggested that a reduction of up to 50% of X rays could be achieved without detriment to the care and treatment of patients. A considerable number of the X-ray procedures carried out today produce no meaningful or useful diagnostic information and it is the elimination of these examinations that would bring about this reduction, as stated by the Irish Institute of Radiography.
One study investigated the use of the chest X-ray (CXR) in a typical urban practice with reference to the Royal College of Radiology (RCR) guidelines. A total of 569 CXRs were performed in 482 patients. Thirty per cent of the CXRs were assessed as being "not indicated" and a significant percentage of requests did not come within the RCR guidelines.
According to the Royal College of Radiologists (RCR) Working Party at least 20% of the radiological examinations carried out in NHS hospitals are clinically unhelpful. This translates over the whole country to an annual total of 7 million unnecessary X-ray examinations costing about £60 million, with the highest numbers of unnecessary X-ray examinations being those of chest and the greatest financial costs arising from examinations of the chest and from barium investigations. , , Unnecessary radiation exposure during medical procedures should be avoided. This is particularly important when the patient is a child, since children exposed to radiation are at a relatively greater risk than adults. The American College of Radiology has noted, "Because they have more rapidly dividing cells than adults and have longer life expectancy, the odds that children will develop cancers from x-ray radiation may be significantly higher than adults." It has been estimated by the National Research Council's Committee on the Biological Effects of Ionizing Radiation that children less than 10 years of age are several times more sensitive to radiation than middle-aged adults .
The VRI device may provide a complementary diagnostic tool for lung examination and aid the physician in determining whether a chest x-ray (CXR) is necessary and thereby reduce the number of negative CXR.
Summary of Clinical Experience The device has already been used for investigational purposes in a number of medical centers (Israel, USA, Europe and Japan). All clinical studies were performed in accordance with the ICH-GCP guidelines as well as the local laws and regulations relevant to the use of new diagnostic devices.
Recorded data was collected and analyzed for more than 3000 adult subjects during a period of more than three years. No related adverse events were reported during the studies.
Study Objective
- The principal objective of the pilot study is to acquire database of pneumonia cases in children.
- The secondary objective is to correlate the clinical and CXR data with the VRI results.
- Keywords
- Pneumonia, Cough, Shortness of breath, VRI
- Medical subject headings
- Pneumonia, Fever, Cough, Dyspnea
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jan 2011 (estimated)
- Study startFeb 2011
- Primary completionAug 2011 (estimated)
- Study completionFeb 2012 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PneumoniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rabin Medical Center
- Sponsor type
- University, hospital or other
- Investigators
- Liora Kornreich, MD, Principal investigator, Schneider Children's Medical Center, IsraelGadi Horev, MD, Study chair, Schneider Children's Medical Center, IsraelMichael Schwarz, MD, Study chair, Schneider Children's Medical Center, IsraelOsnat Konen, MD, Study chair, Schneider Children's Medical Center, IsraelNadine Berkowitz, MD, Study chair, Schneider Children's Medical Center, IsraelYehezkel Waisman, MD, Study chair, Schneider Children's Medical Center, Israel
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01279863
- Sponsor's protocol ID
- 5500-DB048
- Acronym
- VRI
- Status last verified
- May 2010
- First submitted
- 18 Jan 2011
- Last updated
- 12 Aug 2011
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Vibration Response Imaging (VRI) in Children With Acute Respiratory Symptoms.
- ClinicalTrials.gov ID
- NCT01279863
- Acronym / sponsor ID
- VRI / 5500-DB048
- Keywords
- Pneumonia, Cough, Shortness of breath, VRI
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- Rabin Medical CenterUniversity, hospital or other
- Study start
- Feb 2011
- Primary completion
- Aug 2011 (estimated)
- Study completion
- Feb 2012 (estimated)
- First posted
- 19 Jan 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The VRI technology provides a radiation free dynamic image of the lung, by using a combination of well-known technologies, i.e. acoustic sensors, and a proprietary algorithm. The aim of the study is to determine if the VRI examination may contribute to the diagnosis and follow up of pneumonia in children, and therefore reduce the number of chest radiographs and the exposure to ionizing radiation. Children referred by ED for chest x-ray,for the evaluation of pneumonia, will undergo VRI as well. The two modalities will be read independently and then the findings will be compared, in order to asses the potential role of the VRI to the management of pneumonia in children.
Detailed description
Background Several widely used imaging modalities are available today for the human lung. Conventional radiology, CT, and to a lesser extent MRI, as well as nuclear medicine in some indications are well established and most commonly used. Methods using acoustic signals, most notably ultrasound, have not been successfully developed. This is primarily due to the fact that the acoustic damping of the lung parenchyma is prohibitively high at high frequencies .
Assessment of alterations in the structure and function of thoracic organs that occur in disease often gives rise to measurable changes in lung sound production and transmission. Acoustic assessment with a stethoscope is a commonly used method to assess these structural and functional changes. However, auscultation with a stethoscope has many limitations. It is a subjective process that depends on the individual's own hearing, experience and ability to differentiate between different sound patterns. In addition, quantitative measurements and documentation are not easy to be produced. Moreover, the stethoscope has a frequency response that attenuates frequency components of the lung sound signal above 120Hz, and the human ear is not very sensitive to the lower frequency band.
Analysis of acoustic sounds by computer is more likely to be successful in clinical applications when it is based on mathematical models of the underlying physical mechanisms of respiratory sound production. Such models allow for the interaction of mechanical forces, airflow and sound transmission within the respiratory tract to be understood and related to the different disease processes.
The VRI technology, to the best of our knowledge, is the first of its kind to provide a radiation free dynamic image of the lung, by using a combination of well-known technologies, i.e. acoustic sensors, and a proprietary algorithm.
Since the acoustic response of a body depends on its structural properties, complex structures can exhibit acoustic responses, which may vary in space, time and frequency. Moreover, any structural alteration, such as a bronchial obstruction or space occupying infiltration, is reflected by a corresponding modification of the acoustic response.
The VRI takes advantage of this physical principle, by means of an imaging system. By attaching a two dimensional matrix of acoustic transducers to the back of the patient, a dynamic image that integrates the acoustic characteristics of the underlying structure is generated.
The VRI device may provide a complementary diagnostic tool for lung examination and aid the physician in determining whether a chest x-ray should be performed.
Study Device The VRI system is a computerized-based, radiation free device intended for non-invasive recording, audio reproduction, and dynamic image display of vibration response to the airflow during respiration. (The VRI system incorporates a flow volume sensor in which the patient may/may not breathe through it). The VRI system incorporates pressure sensors (electronic stethoscopes) that have been specially adapted to capture and record the energy created by the airflow in the lungs during the respiration process. Sensors are mounted in two sensor matrices, which are attached to the patient's back by a low vacuum and/or biocompatible medical stickers method. The signals are transmitted through wires from the sensor matrix to the hardware board. The analog signals are then processed online on a multi-channels hardware board by amplifying, sampling and A/D conversion. The digital data is transmitted to the PC platform. Once on the PC platform, Deep Breeze proprietary algorithms generate the dynamic lung image.
Risk Analysis Unlike X-Ray based methodologies, which expose the subject to ionization radiation, the VRI is radiation free.
The VRI elements that come into contact with the subject's skin are biocompatible.
The VRI has been approved by an independent authorized laboratory to be electrically safe.
In addition, so far, no adverse events, risks of illness, injuries, or discomforts have been associated with the use of the VRI in previous studies. Therefore, it is reasonable to conclude that the VRI does not pose any risk to the subjects and/or operators.
Study Rationale Various reports and studies have suggested that a reduction of up to 50% of X rays could be achieved without detriment to the care and treatment of patients. A considerable number of the X-ray procedures carried out today produce no meaningful or useful diagnostic information and it is the elimination of these examinations that would bring about this reduction, as stated by the Irish Institute of Radiography.
One study investigated the use of the chest X-ray (CXR) in a typical urban practice with reference to the Royal College of Radiology (RCR) guidelines. A total of 569 CXRs were performed in 482 patients. Thirty per cent of the CXRs were assessed as being "not indicated" and a significant percentage of requests did not come within the RCR guidelines.
According to the Royal College of Radiologists (RCR) Working Party at least 20% of the radiological examinations carried out in NHS hospitals are clinically unhelpful. This translates over the whole country to an annual total of 7 million unnecessary X-ray examinations costing about £60 million, with the highest numbers of unnecessary X-ray examinations being those of chest and the greatest financial costs arising from examinations of the chest and from barium investigations. , , Unnecessary radiation exposure during medical procedures should be avoided. This is particularly important when the patient is a child, since children exposed to radiation are at a relatively greater risk than adults. The American College of Radiology has noted, "Because they have more rapidly dividing cells than adults and have longer life expectancy, the odds that children will develop cancers from x-ray radiation may be significantly higher than adults." It has been estimated by the National Research Council's Committee on the Biological Effects of Ionizing Radiation that children less than 10 years of age are several times more sensitive to radiation than middle-aged adults .
The VRI device may provide a complementary diagnostic tool for lung examination and aid the physician in determining whether a chest x-ray (CXR) is necessary and thereby reduce the number of negative CXR.
Summary of Clinical Experience The device has already been used for investigational purposes in a number of medical centers (Israel, USA, Europe and Japan). All clinical studies were performed in accordance with the ICH-GCP guidelines as well as the local laws and regulations relevant to the use of new diagnostic devices.
Recorded data was collected and analyzed for more than 3000 adult subjects during a period of more than three years. No related adverse events were reported during the studies.
Study Objective
- The principal objective of the pilot study is to acquire database of pneumonia cases in children.
- The secondary objective is to correlate the clinical and CXR data with the VRI results.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
Who may qualify
- Ages
- 3 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Children, 3-18 years old
Key inclusion criteria (5 listed)
- Subject's parent or legal guardian, is able and willing to read the Informed Consent, understands the Informed Consent, and provides written Informed Consent for the subject; if the minor child is in fact able to give consent, the minor's consent must be obtained in addition to the consent of the minor's legal guardian.
- Boy or girl in the age range of 3-18 years.
- Patient presented with acute respiratory complaints, acute cough, onset of shortness of breath, or fever.
- Patient referred by ED physician and presented for CXR.
Key exclusion criteria (4 listed)
- Body habitus or skin condition that might prevent the placement of the sound sensors on the back (e.g. severe scoliosis, kyphosis, chest wall deformation, skin lesion on the back or compression fracture);
- Potentially contagious skin lesion on the back;
- 4. Subject has had lung surgery; 5. Subject was prescribed the CXR for monitoring or follow up of a lung condition that pre-existed the current, acute symptoms.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2011.
Related trials for Pneumonia
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Not yet recruiting
Expanded Diagnostic Strategy in Older Adults Hospitalized With Community-Acquired Acute Respiratory Infection
Acute Respiratory Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Liora Kornreich, MD contact
Liora Kornreich, MD principal investigator
Schneider Children's Medical Center, Israel
Gadi Horev, MD study chair
Schneider Children's Medical Center, Israel
Michael Schwarz, MD study chair
Schneider Children's Medical Center, Israel
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pneumonia and Fever, run by Rabin Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 12 Aug 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Liora Kornreich, MD (liorak@post.tau.ac.il), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2011.